Literature DB >> 6312089

Antiviral activity released from Aedes albopictus cells persistently infected with Semliki forest virus.

S E Newton, L Dalgarno.   

Abstract

Aedes albopictus (mosquito) cells persistently infected with Semliki Forest virus released an agent which inhibited virus production by A. albopictus cells infected with homologous virus. Inhibition of virus production was accompanied by a marked reduction in the synthesis of viral RNA and viral proteins. Expression of the antiviral effect was prevented by pretreatment of cells with actinomycin. No analogous antiviral activity was detected in culture fluids of A. albopictus cells persistently infected with a flavivirus (Kunjin virus) or a bunyavirus (Bunyamwera virus).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312089      PMCID: PMC255308     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  9 in total

1.  Evolution and properties of Aedes albopictus cell cultures persistently infected with sindbis virus.

Authors:  A Igarashi; R Koo; V Stollar
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

2.  Novel antiviral activity found in the media of Sindbis virus-persistently infected mosquito (Aedes albopictus) cell cultures.

Authors:  B Riedel; D T Brown
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

3.  Semliki Forest virus replication in cultured Aedes albopictus cells: studies on the establishment of persistence.

Authors:  M W Davey; L Dalgarno
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

4.  Homologous viral interference in Aedes albopictus cultures chronically infected with Sindbis virus.

Authors:  V Stollar; T E Shenk
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

5.  Semliki Forest virus multiplication in clones of Aedes albopictus cells.

Authors:  P Tooker; S I Kennedy
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

6.  Heterologous interference in Aedes albopictus cells infected with alphaviruses.

Authors:  B T Eaton
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

7.  Bunyamwera virus replication in cultured Aedes albopictus (mosquito) cells: establishment of a persistent viral infection.

Authors:  S E Newton; N J Short; L Dalgarno
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

8.  The Mapputta group of arboviruses: ultrastructural and molecular studies which place the group in the bunyavirus genus of the family Bunyaviridae.

Authors:  S E Newton; N J Short; A M Irving; L Dalgarno
Journal:  Aust J Exp Biol Med Sci       Date:  1983-04

9.  Polypeptide synthesis in alphavirus-infected Aedes albopictus cells during the establishment of persistent infection.

Authors:  M A Richardson; R W Boulton; R S Raghow; L Dalgarno
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  9 in total
  5 in total

Review 1.  Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends.

Authors:  Goro Kuno; Gwong-Jen J Chang
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Suppression of RNA synthesis by a specific antiviral activity in Sindbis virus-infected Aedes albopictus cells.

Authors:  L D Condreay; D T Brown
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  Exclusion of superinfecting homologous virus by Sindbis virus-infected Aedes albopictus (mosquito) cells.

Authors:  L D Condreay; D T Brown
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

Review 4.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

5.  Response to Dengue virus infections altered by cytokine-like substances from mosquito cell cultures.

Authors:  Nipaporn Kanthong; Chaowanee Laosutthipong; Timothy W Flegel
Journal:  BMC Microbiol       Date:  2010-11-16       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.